Ngm Biopharmaceuticals Inc Headquarters
Looking for information about Ngm Biopharmaceuticals Inc Headquarters? The links below have collected all the necessary data.
Contact • NGM Biopharmaceuticals
- https://www.ngmbio.com/contact/
- Headquarters NGM Biopharmaceuticals, Inc. 333 Oyster Point Blvd. South San Francisco, CA 94080 phone: 650.243.5555
NGM Biopharmaceuticals
- https://www.ngmbio.com/
- NGM438 is a novel antagonist antibody inhibiting LAIR1. LAIR1 may form a stromal checkpoint that impedes anti-tumor immunity. Learn More. Powerful Biology. Novel Medicines. Transformative Impact. BECOME AN NGM er. We love working together and challenging each other to pursue great science that will deliver a big impact for patients. Curious ...
NGM Biopharmaceuticals Inc Company Profile - GlobalData
- https://globaldata.com/company-profile/ngm-biopharmaceuticals-inc/competitors/
- NGM Biopharmaceuticals Inc; Key Information: Headquarters: United States of America Headquarter City: SOUTH SAN FRANCISCO Headquarter State/Province: California No. of Employees: 210 Entity Type: Public Key Financials: Revenue (US$ m)-Market Cap (US$ m)-Net Income (US$ m)-EV/Sales-
About • NGM Biopharmaceuticals
- https://www.ngmbio.com/about/
- Founder and Chief Scientific Officer, NGM Biopharmaceuticals. Jin-Long Chen, Ph.D. Founder and Chief Scientific Officer, NGM Biopharmaceuticals. Dr. Chen is NGM’s Founder and has served as a member of our board of directors and as Chief Scientific Officer since January 2008. He was also NGM’s President until November 2014.
NGM Biopharmaceuticals - Crunchbase Company Profile …
- https://www.crunchbase.com/organization/ngm-biopharmaceuticals
- NGM Biopharmaceuticals is a privately-held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic andFounded: 2007
NGM Biopharmaceuticals LinkedIn
- https://www.linkedin.com/company/ngm-biopharmaceuticals
- NGM Biopharmaceuticals Biotechnology South San Francisco, CA 6,366 followers We are focused on discovering and developing transformative therapeutics for patients across multiple therapeutic areas.
NGM - NGM Biopharmaceuticals Inc. • BioPharmCatalyst
- https://www.biopharmcatalyst.com/company/NGM
- Cash, cash equivalents and short-term marketable securities were $390.6 million as of June 30, 2021, compared to $295.2 million as of December 31, 2020. About NGM Biopharmaceuticals, Inc. NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways ...
NGM Biopharmaceuticals Company Profile: Stock …
- https://pitchbook.com/profiles/company/47448-64
- NGM Biopharmaceuticals General Information Description. NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases.
Careers • NGM Biopharmaceuticals
- https://www.ngmbio.com/careers/
- Avantika. Biologics. "NGM is very fast-paced, very dynamic. Because we are a smaller company, you are responsible for a lot. Learning is absolutely encouraged here. We’re challenged to do different things, to learn different things. Management understands that people don’t …
Pipeline • NGM Biopharmaceuticals
- https://www.ngmbio.com/pipeline/
- NGM438 is a novel antagonist antibody being developed by NGM to inhibit Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) for the treatment of advanced solid tumors. LAIR1 is a collagen-binding inhibitory receptor expressed on immune cells 1-2 that is implicated in immune suppression.
Have you found Ngm Biopharmaceuticals Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.